Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial

Cancer medicine(2023)

引用 0|浏览27
暂无评分
关键词
biomarkers,drug design,experimental therapeutics,head and neck cancer,next generation sequencing,salivary gland tumors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要